A progesterona (P4) é um dos principais hormônios responsáveis pela ciclicidade reprodutiva e atua na manutenção da gestação em vacas. Esse hormônio caracteriza-se pela rápida metabolização, o que leva a necessidade de disponibilizá-lo de forma lenta a fim de mimetizar sua liberação fisiológica. Diferentes dispositivos de liberação dos progestágenos associados à aplicação de ésteres de estrógeno são utilizados com frequência em protocolos para sincronizar as ondas foliculares e ovulação. Entre os dispositivos liberadores de progestágenos, o mais utilizado é o intravaginal, sendo disponíveis outras alternativas de dispositivos como o auricular, oral, injetável e o adesivo transdérmico. Dessa forma, conhecer as alternativas de implantes de P4 é importante para garantir a eficiência dos protocolos reprodutivos, assim como o bem-estar animal e o desenvolvimento de novos dispositivos de P4. O objetivo dessa revisão é descrever as principais alternativas de implantes de progesterona utilizados na inseminação artificial em tempo fixo (IATF) bem como suas vantagens e desvantagens.
Summary
The aim of this study was to evaluate the follicular development, morphological integrity, and oxidative stress of preantral ovarian follicles from Bos taurus indicus females grown in vitro with ascorbic acid. Ovaries (n = 20) from Bos taurus indicus females were collected, fragmented, and were cultured in vitro for 6 or 12 days in minimum essential medium (MEM), or MEM supplemented with 50 or 100 ng/ml ascorbic acid, with an extracellular matrix of agarose gel, in an incubator at 38.5°C; every 2 days, 100% of the culture medium was replaced. The data were analyzed using the chi-squared test and/or Fisher’s exact test. In the event of a significant effect, the proportions were compared using a 2 × 2 proportion test. The oxidative stress analysis data were submitted to analysis of variance followed by the Bonferroni test. Values were considered significant when P ≤ 0.05. The addition of 100 ng/ml of ascorbic acid to the in vitro culture medium of preantral ovarian follicles from bovine females promoted follicular development, was efficient in maintaining morphological integrity, as well as the stability of reactive oxygen species, after 6 days of in vitro culture.
We evaluated the effects of nulliparous, primiparous, and multiparous conditions on the estrus and pregnancy rates in females that did not show estrus but were treated with gonadotropin-releasing hormone (GnRH) at the time of timed artificial insemination (TAI). Nelore females (n = 531) were allocated according to the following categories: nulliparous (n = 144), primiparous (n = 132), and multiparous (n = 255). The animals received a conventional TAI protocol, and estrus expression was identified by the absence of paint in the sacrococcygeal region on the day of TAI. Females that did not show estrus were treated with 10 μg of GnRH together with insemination. The rates of estrus and pregnancy were analyzed using a logistic regression model (P < 0.05). The estrus expression was lower (P = 0.006) in the primiparous (61.36%) group than in the nulliparous (76.39%) and multiparous (75.69%) groups. Similar pregnancy rates were observed in females that showed estrus (nulliparous 84.54%, primiparous 86.42%, and multiparous 80.31%; P = 0.39) and in females that did not show estrus and received GnRH (nulliparous 41.18%, primiparous 56.86%, and multiparous 58.06%; P = 0.24). The total pregnancy rates were also similar (P = 0.98) among the categories (nulliparous 74.3%, primiparous 75.0%, and multiparous 74.9%). The primiparous females had a lower rate of estrus, and the pregnancy rates were similar among the categories that received GnRH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.